GTS Securities’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-52,100
Closed -$3.55M 2193
2024
Q3
$3.55M Buy
52,100
+10,900
+26% +$615K 0.01% 1141
2024
Q2
$1.74M Sell
41,200
-37,500
-48% -$2.06M ﹤0.01% 1608
2024
Q1
$5.44M Buy
78,700
+2,900
+4% +$183K 0.01% 809
2023
Q4
$5.61M Buy
75,800
+10,300
+16% +$675K 0.01% 921
2023
Q3
$4.47M Buy
+65,500
New +$5.56M 0.01% 991

Other funds holding EXAS

GTS Securities's EXAS Position: Q4 2025 in Review

GTS Securities sold out of Exact Sciences (EXAS) in Q4 2025, closing a stake of 5,063 shares — an estimated $277K sold.

GTS Securities first reported a position in EXAS in Q2 2023 and held it in 8 quarters. The position peaked at $6.58M in Q4 2023. 710 funds tracked by Wall St. Rank hold EXAS as of Q4 2025.

  • GTS Securities reported no remaining Exact Sciences position as of Q4 2025 after selling out during the quarter.
  • GTS Securities sold 5,063 Exact Sciences shares in Q4 2025, an estimated $277K.
  • GTS Securities first reported a position in Exact Sciences in Q2 2023 and held it in 8 quarters.
  • GTS Securities's Exact Sciences position peaked at $6.58M in Q4 2023.
  • 710 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2025.

Based on GTS Securities's 13F filing for Q4 2025, filed 13 Feb 2026.